Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 6.20% is 27% above its 5-year average of 4.90%, near the high end of its 5-year range (-0.29%–8.02%).
1.64% above its 12-month average of 6.10%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 1.60%.
RETURN ON ASSETS (ROA)
6.20%
RETURN ON ASSETS (ROA) AVG TTM
6.10%
RETURN ON ASSETS (ROA) AVG 3Y
6.22%
RETURN ON ASSETS (ROA) AVG 5Y
4.90%
RETURN ON ASSETS (ROA) AVG 10Y
-4.29%
RETURN ON ASSETS (ROA) AVG 15Y
-1.12%
RETURN ON ASSETS (ROA) AVG 20Y
-2.38%
CURRENT VS TTM AVG
+1.64%
CURRENT VS 3Y AVG
-0.32%
CURRENT VS 5Y AVG
+26.66%
CURRENT VS 10Y AVG
+244.58%
CURRENT VS 15Y AVG
+655.56%
CURRENT VS 20Y AVG
+360.72%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+119.23%
vs the sector median at left
Option Care Health, Inc.
Market Cap
$4.64B
Return on Assets (ROA)
6.20%
TTM Avg
6.10%
3Y Avg
6.22%
5Y Avg
4.90%
Market Cap
$4.60B
Return on Assets (ROA)
4.59%
TTM Avg
-6.29%
3Y Avg
-18.57%
5Y Avg
-18.57%
Market Cap
$4.70B
Return on Assets (ROA)
2.32%
TTM Avg
-1.14%
3Y Avg
-5.25%
5Y Avg
-6.57%
Market Cap
$4.73B
Return on Assets (ROA)
-31.79%
TTM Avg
-38.86%
3Y Avg
-47.00%
5Y Avg
-47.76%
Market Cap
$4.78B
Return on Assets (ROA)
-2.47%
TTM Avg
-26.65%
3Y Avg
-27.96%
5Y Avg
-27.52%
Market Cap
$4.48B
Return on Assets (ROA)
28.79%
TTM Avg
8.79%
3Y Avg
1.95%
5Y Avg
1.56%
Market Cap
$4.83B
Return on Assets (ROA)
-82.32%
TTM Avg
-7.94%
3Y Avg
-19.90%
5Y Avg
-25.16%
Market Cap
$4.84B
Return on Assets (ROA)
-11.66%
TTM Avg
-21.36%
3Y Avg
-19.96%
5Y Avg
-22.39%
Market Cap
$4.37B
Return on Assets (ROA)
-34.36%
TTM Avg
-56.86%
3Y Avg
-55.14%
5Y Avg
-55.14%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Option Care Health, Inc. (OPCH) | $4.64B | 6.20% | 6.10% | 6.22% | 4.90% |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 4.59% | -6.29% | -18.57% | -18.57% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 2.32% | -1.14% | -5.25% | -6.57% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | -31.79% | -38.86% | -47.00% | -47.76% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | -2.47% | -26.65% | -27.96% | -27.52% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | 28.79% | 8.79% | 1.95% | 1.56% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | -82.32% | -7.94% | -19.90% | -25.16% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | -11.66% | -21.36% | -19.96% | -22.39% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | -34.36% | -56.86% | -55.14% | -55.14% |
| Erasca, Inc. (ERAS)vs › | $4.96B | -66.02% | -31.80% | -35.60% | -41.38% |
ROA
6.2%
ROE
16.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 6.01% |
| 2024-12-31 | 6.19% |
| 2023-12-31 | 8.02% |
| 2022-12-31 | 4.66% |
| 2021-12-31 | 4.78% |
| 2020-12-31 | -0.29% |
| 2019-12-31 | -2.93% |
| 2018-12-31 | -1.05% |
| 2017-12-31 | -10.60% |
| 2016-12-31 | -7.04% |
| 2015-12-31 | -54.92% |
| 2014-12-31 | -17.88% |
| 2013-12-31 | -7.43% |
| 2012-12-31 | 10.07% |
| 2011-12-31 | 1.16% |
| 2010-12-31 | -10.41% |
| 2009-12-31 | 18.84% |
| 2008-12-31 | -29.98% |
| 2007-12-31 | 1.12% |
| 2006-12-31 | -12.54% |
| 2005-12-31 | -8.26% |
| 2004-12-31 | 3.77% |
| 2003-12-31 | 5.33% |
| 2002-12-31 | 10.25% |
| 2001-12-31 | 10.16% |
| 2000-12-31 | -1.57% |
| 1999-12-31 | -3.27% |
| 1998-12-31 | 3.91% |
| 1997-12-31 | -21.53% |
| 1996-12-31 | -51.46% |
